FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity

BACKGROUND: To investigate the safety and efficacy of a combined fixed-interval and pro re nata regimen of ranibizumab (FUSION regimen) for treatment of exudative age-related macular degeneration in patients with good visual acuity at baseline. To establish whether similar efficacy to monthly regime...

Descripción completa

Detalles Bibliográficos
Autores principales: Monés, Jordi, Biarnés, Marc, Trindade, Fabio, Casaroli-Marano, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501188/
https://www.ncbi.nlm.nih.gov/pubmed/22527314
http://dx.doi.org/10.1007/s00417-012-2009-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501188/
https://www.ncbi.nlm.nih.gov/pubmed/22527314
http://dx.doi.org/10.1007/s00417-012-2009-5

Ejemplares similares